aTYR PHARMA (ATYR) Shares Outstanding (2019 - 2025)
Historic Shares Outstanding for aTYR PHARMA (ATYR) over the last 7 years, with Q3 2025 value amounting to $98.0 million.
- aTYR PHARMA's Shares Outstanding rose 2925.07% to $98.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.0 million, marking a year-over-year increase of 2925.07%. This contributed to the annual value of $84.0 million for FY2024, which is 3279.14% up from last year.
- Per aTYR PHARMA's latest filing, its Shares Outstanding stood at $98.0 million for Q3 2025, which was up 2925.07% from $92.9 million recorded in Q2 2025.
- In the past 5 years, aTYR PHARMA's Shares Outstanding registered a high of $98.0 million during Q3 2025, and its lowest value of $16.0 million during Q1 2021.
- In the last 5 years, aTYR PHARMA's Shares Outstanding had a median value of $57.0 million in 2023 and averaged $53.6 million.
- As far as peak fluctuations go, aTYR PHARMA's Shares Outstanding soared by 17815.82% in 2021, and later surged by 438.53% in 2022.
- Over the past 5 years, aTYR PHARMA's Shares Outstanding (Quarter) stood at $27.8 million in 2021, then rose by 6.14% to $29.5 million in 2022, then surged by 114.54% to $63.3 million in 2023, then surged by 32.79% to $84.0 million in 2024, then increased by 16.6% to $98.0 million in 2025.
- Its Shares Outstanding stands at $98.0 million for Q3 2025, versus $92.9 million for Q2 2025 and $89.0 million for Q1 2025.